Loading...
01/09 22:04
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong growth in indium phosphide revenue, driven by global demand, particularly outside China. Despite a non-GAAP loss, the company is optimistic about improving gross margins and expanding capacity. The backlog for indium phosphide has more than doubled, and customer interest is high due to product quality. The Q&A session revealed positive analyst sentiment and confidence in future growth. However, the company's cash position has decreased, and some management responses lacked clarity. Overall, the positive growth outlook and strong demand outweigh the financial concerns, suggesting a positive stock price reaction.
Revenue $28.0 million in Q3 2025, up from $18.0 million in Q2 2025 and $23.6 million in Q3 2024, representing a 56% sequential increase and an 18% year-over-year increase. The growth was driven by strong demand for indium phosphide from data center and PON applications.
Indium Phosphide Revenue $13.1 million in Q3 2025, the highest level since 2022, driven by data center and PON applications and successful export permits for significant orders.
Gallium Arsenide Revenue $7.5 million in Q3 2025, up more than 20% from Q2 2025, driven by semi-insulating wafers for wireless RF devices and data center laser applications.
Germanium Substrates Revenue $640,000 in Q3 2025, down by about $1 million from Q2 2025, due to poor gross margin potential and customer preference for sourcing outside China.
Raw Material Joint Venture Revenue $6.7 million in Q3 2025, consistent with Q2 2025, with stable profitability and pricing.
Non-GAAP Gross Margin 22.4% in Q3 2025, up from 8.2% in Q2 2025 but down from 24.3% in Q3 2024. The improvement from Q2 was due to better product mix and higher volume absorption of overhead.
GAAP Gross Margin 22.3% in Q3 2025, up from 8.0% in Q2 2025 but down from 24.0% in Q3 2024, reflecting similar trends as the non-GAAP gross margin.
Non-GAAP Operating Expense $6.7 million in Q3 2025, down from $7.6 million in Q2 2025 and $8.3 million in Q3 2024, due to favorable R&D adjustments and cost control efforts.
GAAP Operating Expense $7.3 million in Q3 2025, down from $8.2 million in Q2 2025 and $9.1 million in Q3 2024, reflecting similar trends as the non-GAAP operating expense.
Non-GAAP Operating Loss $384,000 in Q3 2025, a significant improvement from $6.1 million in Q2 2025 and $2.6 million in Q3 2024, due to higher revenue and better cost management.
GAAP Operating Loss $1.1 million in Q3 2025, improved from $6.7 million in Q2 2025 and $3.4 million in Q3 2024, reflecting similar trends as the non-GAAP operating loss.
Non-GAAP Net Loss $1.2 million or $0.03 per share in Q3 2025, improved from $6.4 million or $0.15 per share in Q2 2025 and $2.1 million or $0.05 per share in Q3 2024.
GAAP Net Loss $1.9 million or $0.04 per share in Q3 2025, improved from $7.0 million or $0.16 per share in Q2 2025 and $2.9 million or $0.07 per share in Q3 2024.
Cash and Cash Equivalents $31.2 million as of September 30, 2025, down by $3.9 million from $35.1 million as of June 30, 2025, due to working capital changes.
Accounts Receivable Increased by $11 million in Q3 2025, contributing to the cash decrease.
Net Inventory $77.7 million in Q3 2025, down by approximately $2.4 million, with further reductions expected in future quarters.
Depreciation and Amortization $2.3 million in Q3 2025.
Stock Compensation $0.7 million in Q3 2025.
Indium Phosphide Revenue: Revenue grew to the highest level since 2022, driven by demand from data center applications globally. Backlog for indium phosphide orders is over $49 million and growing.
Gallium Arsenide Revenue: Revenue grew more than 20% from the prior quarter, driven by semi-insulating wafers for wireless RF devices and data center laser applications.
Geographic Demand: Massive AI infrastructure build-out in the U.S. and data center expansion in China are driving demand for indium phosphide substrates.
New Customer Engagement: Active engagement with new Tier 1 customers globally, including leading optical transceiver module makers.
Export Permits: Export permits for indium phosphide orders are taking approximately 60 business days to process, impacting delivery timelines.
Manufacturing Capacity: Ample manufacturing capacity is in place to handle increased demand, with the ability to scale up quickly.
IPO of Tongmei: Continued progress on listing subsidiary Tongmei on the STAR Market in Shanghai, despite geopolitical challenges.
Operational Efficiency: Focus on improving gross margins, reducing operating expenses, and managing inventory to drive profitability.
Export Permits: The company faces delays in obtaining export permits for indium phosphide and gallium arsenide, which is a significant gating factor for growth. The process takes approximately 60 business days, and holidays like China's Golden Week can further extend this timeline. This creates uncertainty in revenue realization and impacts customer order fulfillment.
Geopolitical Complexities: Geopolitical tensions and trade restrictions are influencing customer behaviors and creating challenges in securing export permits. These complexities add uncertainty to the company's operations and strategic planning.
Germanium Substrates: The germanium substrate market has poor gross margin potential, and certain customers prefer sourcing outside of China. This limits growth opportunities in this segment.
Cash Flow and Working Capital: Cash and cash equivalents decreased by $3.9 million, and accounts receivable increased by $11 million, indicating potential cash flow challenges. Inventory levels remain high, although there is a focus on reduction.
Regulatory and Environmental Risks: Increased environmental regulations in China could impact the financial performance of the company's partially owned supply chain companies.
Operational Efficiency: The company is under pressure to improve gross margins, reduce operating expenses, and manage inventory levels effectively to return to profitability.
Indium Phosphide Demand: Strong increase in demand driven by AI and data center upgrade cycles. Backlog has grown to $49 million, the largest in company history. Customers are placing longer-term orders and providing greater visibility into their needs.
Revenue Guidance for Q4 2025: Expected revenue range of $27 million to $30 million, contingent on obtaining export permits. Approximately $20 million in revenue is highly confident, with an additional $7 million to $10 million dependent on permit approvals.
Gross Margin Improvement: Continued focus on manufacturing efficiency and gross margin improvement. Further gains in Q4 depend on revenue mix, total revenue, and manufacturing efficiency.
Operating Expenses (OpEx): Expected to increase to approximately $9 million in Q4 due to end-of-year adjustments and normalization.
Net Loss Guidance for Q4 2025: Non-GAAP net loss expected to be in the range of $0.01 to $0.03 per share. GAAP net loss expected to be in the range of $0.03 to $0.05 per share.
Geopolitical and Export Permit Challenges: Export permits remain a significant gating factor for growth. Timing and success of obtaining permits are critical for realizing revenue.
Data Center Market Trends: Massive AI infrastructure build-out and planned CapEx spending by cloud services and AI platform providers in the U.S. are primary drivers. Healthy growth expected in China's data center market over the next 12 to 18 months.
Manufacturing Capacity: Ample manufacturing capacity in place to handle increased demand. Ability to add capacity quickly as needed.
The selected topic was not discussed during the call.
The earnings call indicates strong growth in indium phosphide revenue, driven by global demand, particularly outside China. Despite a non-GAAP loss, the company is optimistic about improving gross margins and expanding capacity. The backlog for indium phosphide has more than doubled, and customer interest is high due to product quality. The Q&A session revealed positive analyst sentiment and confidence in future growth. However, the company's cash position has decreased, and some management responses lacked clarity. Overall, the positive growth outlook and strong demand outweigh the financial concerns, suggesting a positive stock price reaction.
The earnings call summary shows mixed signals: improvements in gross margins and operating expenses are positive, but ongoing losses and cash depletion are concerning. The Q&A reveals potential growth in indium phosphide demand, but uncertainties in export licenses and permitting delays pose risks. The company's optimistic guidance and backlog could boost stock, but lack of clarity on license issues tempers this optimism. The absence of a market cap makes it hard to predict volatility, but overall, the sentiment is balanced, leading to a neutral stock price prediction.
The earnings call reveals significant challenges: a 15% revenue drop, negative gross margins due to yield issues, and geopolitical/export restrictions impacting operations. Despite management's optimism about resolving yield problems, their vague responses in the Q&A raise doubts. The absence of a share repurchase program and worsening financial losses further contribute to a negative outlook. Given the critical risks and lack of positive catalysts, the stock is likely to experience a strong negative reaction (>8% decline) over the next two weeks.
The earnings call reveals mixed signals. While revenue increased and long-term growth is expected, short-term challenges like reduced gross margins, increased operating expenses, and significant net losses are concerning. The Q&A highlights potential export restrictions impacting Q1 sales and unclear management responses, further contributing to uncertainty. The absence of a share repurchase program and customer concentration risk add to the negative outlook. Despite some positive aspects, such as growth in fiscal year revenue and optimism for 2025, the immediate negative factors are likely to outweigh, predicting a negative stock price reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
